BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15684088)

  • 1. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.
    Veldic M; Guidotti A; Maloku E; Davis JM; Costa E
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2152-7. PubMed ID: 15684088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains.
    Veldic M; Caruncho HJ; Liu WS; Davis J; Satta R; Grayson DR; Guidotti A; Costa E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):348-53. PubMed ID: 14684836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures.
    Noh JS; Sharma RP; Veldic M; Salvacion AA; Jia X; Chen Y; Costa E; Guidotti A; Grayson DR
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1749-54. PubMed ID: 15671176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
    Dong E; Agis-Balboa RC; Simonini MV; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12578-83. PubMed ID: 16113080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.
    Matrisciano F; Tueting P; Dalal I; Kadriu B; Grayson DR; Davis JM; Nicoletti F; Guidotti A
    Neuropharmacology; 2013 May; 68():184-94. PubMed ID: 22564440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.
    Kundakovic M; Chen Y; Costa E; Grayson DR
    Mol Pharmacol; 2007 Mar; 71(3):644-53. PubMed ID: 17065238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
    Dong E; Ruzicka WB; Grayson DR; Guidotti A
    Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder.
    Veldic M; Kadriu B; Maloku E; Agis-Balboa RC; Guidotti A; Davis JM; Costa E
    Schizophr Res; 2007 Mar; 91(1-3):51-61. PubMed ID: 17270400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
    Kundakovic M; Chen Y; Guidotti A; Grayson DR
    Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
    Grayson DR; Chen Y; Costa E; Dong E; Guidotti A; Kundakovic M; Sharma RP
    Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
    Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
    Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
    Tremolizzo L; Carboni G; Ruzicka WB; Mitchell CP; Sugaya I; Tueting P; Sharma R; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17095-100. PubMed ID: 12481028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas.
    Rodriguez MA; Caruncho HJ; Costa E; Pesold C; Liu WS; Guidotti A
    J Comp Neurol; 2002 Sep; 451(3):279-88. PubMed ID: 12210139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis.
    Guidotti A; Ruzicka W; Grayson DR; Veldic M; Pinna G; Davis JM; Costa E
    Neuroreport; 2007 Jan; 18(1):57-60. PubMed ID: 17259861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability.
    Costa E; Grayson DR; Mitchell CP; Tremolizzo L; Veldic M; Guidotti A
    Crit Rev Neurobiol; 2003; 15(2):121-42. PubMed ID: 14977367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes.
    Zhubi A; Veldic M; Puri NV; Kadriu B; Caruncho H; Loza I; Sershen H; Lajtha A; Smith RC; Guidotti A; Davis JM; Costa E
    Schizophr Res; 2009 Jun; 111(1-3):115-22. PubMed ID: 19386473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.
    Zhubi A; Chen Y; Guidotti A; Grayson DR
    Int J Dev Neurosci; 2017 Nov; 62():63-72. PubMed ID: 28229923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation.
    Dong E; Grayson DR; Guidotti A; Costa E
    Epigenomics; 2009 Oct; 1(1):201-11. PubMed ID: 22122643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
    Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.
    Guidotti A; Dong E; Kundakovic M; Satta R; Grayson DR; Costa E
    Trends Pharmacol Sci; 2009 Feb; 30(2):55-60. PubMed ID: 19110320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.